CLINICAL_TRIALS trial_result · 2024-05-14

Clinical Trial Update: A Study of TAK-071 in People With Parkinson Disease [Phase 2]

A Phase 2 study of TAK-071 in people with Parkinson disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Parkinson Disease, Healthy Participants | Phase 2 | Status: COMPLETED | Results posted: 2024-05-14